New Zealand Set to Legalize Hemp Seed Market | CashCropToday
0 Shares 178 Views

New Zealand Set to Legalize Hemp Seed Market

February 21, 2018
178 Views

New Zealand’s industrial hemp industry is going commercial this year. New laws are expected to take place that will allow farmers and entrepreneurs the opportunity go grow industrial hemp for seed propagation.

Hemp seeds are  extremely beneficial to one’s health, as they are filled with numerous vitamins and minerals, as well as large amounts of amino acids, fiber, and fatty acids. Hemp seeds are regularly compared to superfoods like quinoa and high-protein meat sources, and they can also be processed into a number of finished goods.

Top companies in Canada like Nutiva and Manitoba Harvest dominate the North America market with products like hemp protein powder, hemp oil, and healthy hemp hearts.  This year New Zealand expects to triple the 200 to 300ha of acres of hemp plants grown annually and farmers can now expect to see returns of $4500 to $5500 a hectare. The change in legislation also plans to generate $10M- $20M in export revenue a year.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
270 views
Market Watch
270 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
194 views
Global
194 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
190 views
Manufacturing
190 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: